Showing results (1841-1850 of 1,881) with videos related to
Sort By:
Pageof 189
Immunotherapy|May 25, 2026
CAR-iNKT cells for cancer therapy: a comprehensive review of engineering, mechanisms, and clinical progressYing Yang, Jiaqi Gu, Yujie Ding, et al.Immunotherapy|May 4, 2026
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapyHarshad S Kapare, Rutuja Jadhav, Pawan N Karwa, et al.Immunotherapy|May 27, 2026
Disrupting neuro-immune feedback loops: novel targets to amplify cancer immunotherapyAbbas Jafari, Kovsar Mohammadnezhadharmileh, Maryam Majidinia, et al.Immunotherapy|March 18, 2026
Immunotherapy of endometrial cancer: a review of recent advancesKrešimir Tomić, Kristina Katić, Zoran Gatalica, et al.Immunotherapy|March 12, 2026
Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial carcinoma: a systematic review and meta-analysisAna Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Luana Diniz Guerra Braz, et al.Immunotherapy|March 3, 2026
Financial barriers to immunotherapy: challenges and potential mitigation strategies: a review paperHasan Numan, Arafat TfayliImmunotherapy|June 12, 2026
Refining adjuvant therapy options in patients with stage II melanomaBryant Morocho, Sasha Lightfoot, Ponnandai Somasundar, et al.Immunotherapy|April 11, 2026
Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction cancer: KEYNOTE-859 Q-TWiST analysisLucjan Wyrwicz, Vasiliki Kalampoki, Adriana Valderrama, et al.Immunotherapy|April 22, 2026
Immune checkpoint inhibitors in POLE/POLD1 proofreading-deficient CRC: from molecular basis to clinical practice and future directionsLei Jiang, Zhongxia Yang, Xiaojun LiuImmunotherapy|May 4, 2026
Oncolytic viruses in brain cancer therapy: advances, challenges, and clinical trial outcomesYaser Arjeini, Sara Khalili Dermani, Sanaz Sadeh, et al.Pageof 189